Skip to main content
Clinical Trials/NCT04088201
NCT04088201
Unknown
Not Applicable

Epidermal Adhesive Sensors to Enhance Continuous Glucose Measurement in Patients With Diabetes: The EASE Study

University of California, San Diego1 site in 1 country50 target enrollmentSeptember 26, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
University of California, San Diego
Enrollment
50
Locations
1
Primary Endpoint
Interstitial fluid glucose readings
Last Updated
5 years ago

Overview

Brief Summary

Self-testing of glucose by patients living with diabetes mellitus (DM) involves needles, which can cause discomfort or inconvenience; these and other factors can lead to decreased willingness to perform these checks that are vital to DM management. While technology has evolved, a needle-free glucose monitoring device is currently not available. The investigators are studying a glucose sensor that adheres to the skin, similarly to a temporary tattoo. This sensor can now obtain continuous readings. As it has not yet been tested in individuals with DM, this study will examine its accuracy and acceptability in these patients. Results from this clinical trial could serve as the basis for further development of a non-invasive, wearable glucose sensor that can provide measurements of glucose levels continuously.

Registry
clinicaltrials.gov
Start Date
September 26, 2019
End Date
June 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Edward Chao

Clinical Professor of Medicine

University of California, San Diego

Eligibility Criteria

Inclusion Criteria

  • An existing diagnosis of diabetes mellitus, either T1DM or T2DM, or any other type or etiology of diabetes
  • Ability to provide informed consent for participation.

Exclusion Criteria

  • Individuals without diabetes
  • Those who cannot speak or read English. We are limiting participation to those who read and speak English, as this is a pilot study of a small number of participants, that will very unlikely offer the prospect of direct benefit from participating.
  • Individuals who have frequent hypoglycemia, hypoglycemia unawareness, or who are at high risk for hypoglycemia.

Outcomes

Primary Outcomes

Interstitial fluid glucose readings

Time Frame: Hourly, up to 8 hours

Needle-less measurements with an epidermal sensor - pls note, study is to assess how sensor readings compare with those from a glucometer

Secondary Outcomes

  • Acceptablility of sensor(At end of study testing sessions, at 8 hours)

Study Sites (1)

Loading locations...

Similar Trials